Molecular Therapy

FIGURE 2

FROM:

Rat Strain Differences in the Ectopic Osteogenic Potential of Recombinant Human BMP Adenoviruses

Jin Zhong Li, Hongwei Li, Brad Dunford, David Holman, Brian Beres, Debra D. Pittman, Gerald R. Hankins and Gregory A. Helm

BACK TO ARTICLE

Figure 2.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

The titers of adenoviral neutralizing antibody in different rat strains 30 days post-viral injection. The titer of adenoviral neutralizing antibody represents 97% inhibition of ADCMVGFP. W, Wistar rats; LE, Long-Evans rats; SD, Sprague-Dawley rats; ACI, ACI rats; PVG, PVG rats; F, Fischer344 rats. Error bars represent standard error.

BACK TO ARTICLE